Omega Healthcare Investors (NYSE:OHI) had its price objective dropped by investment analysts at Raymond James from $40.00 to $38.00 in a report released on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Raymond James’ price target indicates a potential upside of 21.48% from the stock’s previous close.
OHI has been the subject of a number of other research reports. Capital One Financial lowered shares of Omega Healthcare Investors from an “overweight” rating to an “equal weight” rating and set a $38.00 target price for the company. in a research report on Wednesday, August 4th. Scotiabank downgraded shares of Omega Healthcare Investors from a “sector outperform” rating to a “sector perform” rating and decreased their price target for the company from $41.00 to $39.00 in a research note on Thursday, June 17th. They noted that the move was a valuation call. Zacks Investment Research raised shares of Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, August 18th. Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company an “overweight” rating in a research note on Friday, July 23rd. Finally, JMP Securities downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a research note on Monday, September 13th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $39.33.
OHI opened at $31.28 on Thursday. The firm has a market cap of $7.47 billion, a P/E ratio of 34.00, a PEG ratio of 5.34 and a beta of 0.99. Omega Healthcare Investors has a 1-year low of $28.08 and a 1-year high of $39.31. The company has a 50 day simple moving average of $34.40 and a two-hundred day simple moving average of $36.17. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.65 and a quick ratio of 3.65.
In related news, insider Steven J. Insoft sold 25,000 shares of the firm’s stock in a transaction dated Friday, June 25th. The shares were sold at an average price of $36.71, for a total value of $917,750.00. Following the transaction, the insider now owns 184,588 shares of the company’s stock, valued at approximately $6,776,225.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In the last three months, insiders bought 1,755 shares of company stock worth $62,479. Insiders own 1.16% of the company’s stock.
A number of hedge funds have recently bought and sold shares of OHI. MV Capital Management Inc. purchased a new position in Omega Healthcare Investors in the 2nd quarter worth about $25,000. Tradition Wealth Management LLC increased its stake in Omega Healthcare Investors by 133.3% in the 2nd quarter. Tradition Wealth Management LLC now owns 700 shares of the real estate investment trust’s stock worth $25,000 after buying an additional 400 shares during the period. Stonebridge Capital Advisors LLC purchased a new position in Omega Healthcare Investors in the 1st quarter worth about $26,000. Edmond DE Rothschild Holding S.A. purchased a new position in Omega Healthcare Investors in the 1st quarter worth about $29,000. Finally, Capital Analysts LLC purchased a new position in Omega Healthcare Investors in the 1st quarter worth about $32,000. 68.50% of the stock is currently owned by institutional investors.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities. Its portfolio consists of long-term leases and mortgage agreements. The company was founded on March 31, 1992 and is headquartered in Hunt Valley, MD.
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.